<DOC>
	<DOC>NCT02094118</DOC>
	<brief_summary>This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.</brief_summary>
	<brief_title>Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications</brief_title>
	<detailed_description />
	<mesh_term>Transfusion Reaction</mesh_term>
	<criteria>Age equal to or greater than 18 years of age. Scheduled to have cardiac bypass surgery at Mayo Clinic in Rochester, Minnesota or Duke University Medical Center in Durham, North Carolina At risk for needing at least 4 units of blood during/after surgery Emergency surgery Immunoglobulin A (IgA) deficiency History of severe recurrent transfusion reactions Refusal to receive allogeneic blood products Refusal to provide informed consent Prevalent lung injury prior to randomization Prevalent congestive heart failure prior to randomization Expected hospital stay &lt; 48 hours Not anticipated to survive &gt; 48 hours Previously enrolled in this trial No plan for placement of a pulmonary artery catheter Use of home oxygen therapy Complex RBC antibody profiles Need for the use of irradiated RBCs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Transfusion</keyword>
	<keyword>RBC</keyword>
	<keyword>cardiac</keyword>
	<keyword>surgery</keyword>
	<keyword>transfusion related acute lung injury (TRALI)</keyword>
	<keyword>transfusion associated circulatory overload (TACO)</keyword>
</DOC>